BSE filing, NSE: SIKA. Summary written from the filing by ALFA Finder's alert engine.
Sika Interplant Systems Ltd: key numbers
- Share price
- ₹875.00
- Market cap
- ₹1,855 Cr
- Revenue (annual)
- ₹211.2 Cr
- Net profit (annual)
- ₹36.44 Cr
- P/E (TTM)
- 53.5×Sector 52.2×
- Promoter holding
- 71.72%+0.00% QoQ
- FII holding
- 3.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sika Interplant Systems Ltd
All →Sika Interplant Systems Business Update
Sika Interplant Systems disclosed that supply-chain disruptions caused by geopolitical tensions led to delays in order execution and revenue deferment for the June 2026 quarter.
Sika Interplant Systems Q1 FY27 Results: Net Profit ₹8.4 Cr, Down 19.2% YoY
Sika Interplant Systems Ltd reported revenue from operations of ₹42.9 Cr (-36.9% YoY) and net profit of ₹8.4 Cr (-19.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹8.4 Cr · -19.2% YoY
Sika Interplant Systems Annual General Meeting
Sika Interplant Systems held its 40th Annual General Meeting on August 12, 2026. Shareholders considered agenda items including financial statements and a dividend declaration.
Sika Interplant Systems Board Meeting Date
Sika Interplant Systems Ltd will hold a board meeting on August 14, 2026, to consider the unaudited financial results for the quarter ended June 30, 2026.
Sika Interplant Systems Annual General Meeting
Sika Interplant Systems Limited has issued the notice for its 40th Annual General Meeting, scheduled for August 12, 2026, along with its Annual Report.
Sika Interplant Systems Price Movement Clarification
Sika Interplant Systems clarified that recent share price fluctuations are market-driven. The company confirms no undisclosed price-sensitive information exists.
Other other announcement announcements
All →Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM
Kalpataru Other Announcement
Kalpataru filed CARE Ratings' IPO monitoring report for the quarter ended September 30, 2026. It reports no deviation from offer objects, though fund co-mingling was noted.
Rnit AI Solutions Other Announcement
RNIT AI Solutions filed its quarterly Reg 32 statement for the preferential issue. It reports no deviation in use of funds.
Persistent Systems Other Announcement
Persistent Systems filed its shareholding pattern for 26 October 2026, reflecting the increase in paid-up capital from its QIP allotment. The filing shows the post-allotment shareholding split.